In vivo modulation of HDL phospholipid has opposing effects on SR-BI- and ABCA1-mediated cholesterol efflux

Area of Science:

• Lipid metabolism
• Cardiovascular research
• Biochemistry

Background:

• High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport.
• Scavenger receptor class BI (SR-BI) and ATP binding cassette transporter 1 (ABCA1) are key mediators of cholesterol efflux from cells to HDL.
• The phospholipid (PL) composition of HDL influences its function in cholesterol transport.

Purpose of the Study:

• To investigate the in vivo effects of modulating HDL phospholipid content on SR-BI and ABCA1-mediated cholesterol efflux.
• To determine how different lipases, endothelial lipase (EL) and phosphatidylserine phospholipase (PS-PLA1), impact HDL function and cholesterol efflux pathways.

Main Methods:

• Overexpression of endothelial lipase (EL) or phosphatidylserine phospholipase (PS-PLA1) in human apolipoprotein A-I (apoA-I) transgenic mice.
• Measurement of serum phospholipid/apoA-I ratio, total cholesterol, HDL cholesterol, and HDL size.
• Assessment of cholesterol efflux potential via SR-BI and ABCA1 using mouse serum.

Main Results:

• EL overexpression significantly reduced HDL phospholipids, cholesterol, and SR-BI-mediated efflux, while increasing ABCA1-mediated efflux.
• PS-PLA1 overexpression increased HDL phospholipids, cholesterol, HDL size, and SR-BI-mediated efflux, while decreasing ABCA1-mediated efflux.
• Serum parameters showed significant positive correlations with SR-BI efflux and inverse correlations with ABCA1 efflux.

Conclusions:

• In vivo modulation of HDL phospholipid content reciprocally affects SR-BI and ABCA1-mediated cholesterol efflux.
• The type of lipase acting on HDL determines the primary cholesterol efflux pathway utilized.
• The extent of lipolysis influences the efficiency of cholesterol removal via these pathways.